Caption Management’s Boston Scientific BSX Stock Holding History

Caption Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.3M	Sell	312,050 -62,350	-17%	-$3.39M	0.06%	322
2026 Q1	$23.5M	Buy	374,400 +283,400	+311%	+$22.7M	0.14%	150
2025 Q4	$8.68M	Sell	91,000 -9,800	-10%	-$961K	0.06%	369
2025 Q3	$9.84M	Buy	+100,800	New	+$10.4M	0.08%	285
2025 Q1	–	Sell	-9,833	Closed	-$990K	–	1552
2024 Q4	$878K	Buy	+9,833	New	+$866K	0.01%	956
2024 Q1	–	Sell	-46,620	Closed	-$2.7M	–	1232
2023 Q4	$2.7M	Buy	+46,620	New	+$2.49M	0.04%	526
2022 Q4	–	Sell	-12,500	Closed	-$485K	–	1299
2022 Q3	$485K	Buy	+12,500	New	+$501K	0.01%	1079
2022 Q2	–	Sell	-48,966	Closed	-$2.17M	–	1478
2022 Q1	$2.17M	Buy	+48,966	New	+$2.12M	0.03%	725
2021 Q4	–	Sell	-27,000	Closed	-$1.17M	–	1611
2021 Q3	$1.17M	Buy	+27,000	New	+$1.19M	0.01%	971
2019 Q2	–	Sell	-9,900	Closed	-$380K	–	666
2019 Q1	$380K	Sell	9,900 -73,100	-88%	-$2.79M	0.02%	458
2018 Q4	$2.93M	Buy	+83,000	New	+$3.01M	0.23%	129

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Caption Management's BSX Position: Q2 2026 in Review

Caption Management reduced its Boston Scientific (BSX) stake by 17% in Q2 2026, selling an estimated $3.39M and leaving 312,050 shares worth $13.3M. The position accounts for 0.06% of the portfolio, ranked #322.

Caption Management first reported a position in BSX in Q4 2018 and has held it in 11 quarters since. The position peaked at $23.5M in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Caption Management held 312,050 shares of Boston Scientific worth $13.3M as of Q2 2026.
Caption Management sold 62,350 Boston Scientific shares in Q2 2026, an estimated $3.39M.
Boston Scientific made up 0.06% of Caption Management's portfolio in Q2 2026, its #322 holding.
Caption Management first reported a position in Boston Scientific in Q4 2018 and has held it in 11 quarters since.
Caption Management's Boston Scientific position peaked at $23.5M in Q1 2026.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.